Ticker

Analyst Price Targets — MTA

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
July 14, 2026 4:36 pmEric WinmillScotiabank$8.50$7.33TheFly Metalla Royalty & Streaming price target lowered to $8.50 from $9 at Scotiabank
October 23, 2025 1:22 pmScotiabank$7.50$7.16TheFly Metalla Royalty & Streaming price target raised to $7.50 from $5 at Scotiabank

Latest News for MTA

METALLA ANNOUNCES VOTING RESULTS FROM ANNUAL GENERAL MEETING AND INVESTMENT FROM SANDEEP SINGH

TSXV: MTA NYSE AMERICAN: MTA VANCOUVER, BC, June 23, 2026 /PRNewswire/ - Metalla Royalty & Streaming Ltd. ("Metalla" or the "Company") (NYSE American: MTA) (TSXV: MTA) is pleased to announce the voting results for its annual general meeting of shareholders held on June 23, 2026 (the "Meeting") where all director nominations and other items recommended by the board of directors of the Company (the "Board") were…

PRNewsWire • Jun 23, 2026
METALLA PUBLISHES 2026 ASSET HANDBOOK AND ANNUAL LETTER TO SHAREHOLDERS

TSXV: MTA NYSE AMERICAN:  MTA VANCOUVER, BC, June 23, 2026 /PRNewswire/ - Metalla Royalty & Streaming Ltd. ("Metalla" or the "Company") (NYSE American: MTA) (TSXV: MTA) is pleased to announce the release of its 2026 Asset Handbook outlining the Company's high-quality gold, silver, and copper production, development, and exploration assets, as well as Mineral Reserve and Mineral Resource data.

PRNewsWire • Jun 23, 2026
IDEAYA Biosciences Announces IDE892, a Potential Best-in-Class MTA-Cooperative PRMT5 Inhibitor, Initiates a Phase 1/2 Clinical Combination Study in MTAP-Deleted Pancreatic and Lung Cancers

IDE892 is a potential best-in-class MTA-Cooperative PRMT5 combination partner with MAT2A and pan-RAS inhibitors, with favorable drug-like properties IDE892 has a CYP3A4 IC50 greater than 45 micromolar, and did not show time dependent inhibition of any of the 7 major cytochrome P450s (CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4) based on full kinetic CYP inactivation assays IDE892 monotherapy Phase 1…

PRNewsWire • Jun 15, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for MTA.

No Senate trades found for MTA.

No House trades found for MTA.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top